GLP-1 RAs and cardiovascular protection for your type 2 diabetes patient
In this CPD-accredited report, experts review the latest findings for the cardiovascular complications of diabetes.
You will learn:
• Current evidence on the cardiovascular protection benefits of GLP-1 RA therapy
• In daily clinical practice, the T2DM patient’s cardiovascular risk should be addressed as early as possible.